iXensor Co., Ltd. (TPEX:6734)
4.710
-0.270 (-5.42%)
Nov 20, 2026, 1:51 PM CST
iXensor Market Cap
iXensor has a market cap or net worth of 191.33 million as of November 20, 2026. It is the 43,901st most valuable company in the world and the 2,353rd biggest in Taiwan. Its market cap has increased by 0.77% in one year.
Market Cap
191.33M
Enterprise Value
200.07M
Revenue
26.67M
Global Rank
Country Rank
#2,353 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 28, 2019, iXensor's market cap has decreased from 1.69B to 191.33M, a decrease of -88.69%. That is a compound annual growth rate of -25.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 191.33M | 6.80% |
| Dec 31, 2025 | 179.15M | 2.45% |
| Dec 31, 2024 | 174.86M | -61.87% |
| Dec 29, 2023 | 458.61M | -27.92% |
| Dec 30, 2022 | 636.21M | -13.24% |
| Dec 30, 2021 | 733.29M | -27.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiant Innovation | 745.23M |
| AmCad BioMed | 699.83M |
| Carilex Medical | 651.76M |
| Cowealth Medical Holding | 635.72M |
| PlexBio | 518.25M |
| DuoGenic StemCells corporation | 409.41M |
| A-SPINE Asia | 405.48M |
| Health & Life | 360.30M |